SKRINING DEPRESIVNIH I ANKSIOZNIH POREMEĆAJA KOD ADOLESCENATA OBOLELIH OD EPILEPSIJE
DOI:
https://doi.org/10.46793/PP241127002RKljučne reči:
skrinig, depresija, ansioznost, adolescenti, epilepsijaApstrakt
Epilepsija je najčešća hronična neurološka bolest u detinjstvu koja negativno utiče na fizičko, psihološko i socijalno funkcionisanje obolelih i njihovih porodica. Adolescenti oboleli od epilepsije u 21-60% slučajeva imaju narušeno i mentalno zdravlje, najčešće u vidu depresivnih i i anksioznih poremećaja, što ima značaj uticaj na njihov kvalitet života. Depresija povećava rizik od problema u ponašanju, zloupotrebe supstanci i drugih socijalnih problema. Anksiozni poremećaji, poput paničnog poremećaja i socijalne fobije, mogu da evaluiraju u ozbiljnija psihopatološka stanja. Ovi poremećaji često ostaju neprepoznati i nedovoljno lečeni, što povećava rizik od pogoršanja simptoma. Značajno je sprovoditi pravovremeni skrining depresivnih i anksioznih simptoma kod adolescenata sa epilepsijom. Preporuka je da se tokom kontrolnih pregleda adolescenata obolelih od epilepsije implementiraju skrining upitnici za rano otkrivanje ovih poremećaja. Pravovremeno prepoznavanje simptoma depresije i anksioznosti omogućava adekvatno usmeravanje na psihološke tretmane, što može poboljšati kvalitet života pacijenata, komplijansu i smanjiti rizik od pogoršanja bolesti.
Reference
Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475-482. doi: 10.1111/epi.12550. PMID: 24730690.
Aaberg KM, Gunnes N, Bakken IJ, Lund Søraas C, Berntsen A, Magnus P, et al. Incidence and Prevalence of Childhood Epilepsy: A Nationwide Cohort Study. Pediatrics. 2017;139(5):e20163908. doi: 10.1542/peds.2016-3908. PMID: 28557750.
Beghi E. The Epidemiology of Epilepsy. Neuroepidemiology. 2020;54(2):185-191. doi: 10.1159/000503831. PMID: 31852003.
Forsgren L, Hauser WA, Olafsson E, Sander JW, Sillanpää M, Tomson T. Mortality of epilepsy in developed countries: a review. Epilepsia. 2005;46 Suppl 11:18-27. doi: 10.1111/j.1528-1167.2005.00403.x. PMID: 16393174.
Minardi C, Minacapelli R, Valastro P, Vasile F, Pitino S, Pavone P, et al. Epilepsy in Children: From Diagnosis to Treatment with Focus on Emergency. J Clin Med. 2019 2;8(1):39. doi: 10.3390/jcm8010039. PMID: 30609770.
Ott D, Siddarth P, Gurbani S, Koh S, Tournay A, Shields WD, et al. Behavioral disorders in pediatric epilepsy: unmet psychiatric need. Epilepsia. 2003;44(4):591-597. doi: 10.1046/j.1528-1157.2003.25002.x. PMID: 12681010.
Ekinci O, Titus JB, Rodopman AA, Berkem M, Trevathan E. Depression and anxiety in children and adolescents with epilepsy: prevalence, risk factors, and treatment. Epilepsy Behav. 2009;14(1):8-18. doi: 10.1016/j.yebeh.2008.08.015. PMID: 18804186.
Adewuya AO, Oseni SB. Impact of psychiatric morbidity on parent-rated quality of life in Nigerian adolescents with epilepsy. Epilepsy Behav. 2005;7(3):497-501. doi: 10.1016/j.yebeh.2005.07.011. PMID: 16143568.
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Arlington, VA: American Psychiatric Association; 2013. p. 155-158.
Ministarstvo zdravlja Republike Srbije. Nacionalni vodič dobre kliničke prakse za dijagnostikovanje i lečenje depresije, Beograd, 2011. p. 92-3.
Penninx BW, Pine DS, Holmes EA, Reif A. Anxiety disorders. Lancet. 2021 6;397(10277):914-927. doi: 10.1016/S0140-6736(21)00359-7. Erratum in: Lancet. 2021;397(10277):880. doi: 10.1016/S0140-6736(21)00473-6. PMID: 33581801.
Ströhle A, Gensichen J, Domschke K. The Diagnosis and Treatment of Anxiety Disorders. Dtsch Arztebl Int. 2018;155(37):611-620. doi: 10.3238/arztebl.2018.0611
Coppola G, Operto FF, Matricardi S, Verrotti A. Monitoring And Managing Depression In Adolescents With Epilepsy: Current Perspectives. Neuropsychiatr Dis Treat. 2019;15:2773-2780. doi: 10.2147/NDT.S192714. PMID: 31576132.
Dunn DW, Austin JK, Perkins SM. Prevalence of psychopathology in childhood epilepsy: categorical and dimensional measures. Dev Med Child Neurol. 2009;51(5):364-372. doi: 10.1111/j.1469-8749.2008.03172.x. PMID: 19018836.
US Preventive Services Task Force. Screening and Treatment for Major Depressive Disorder in Children and Adolescents: Recommendation Statement. Am Fam Physician 2010;82:178–179.
Wong J, Gill J, Rees G, et al. Screening for Depression in Adolescents with Epilepsy. JAMA 2020;324(24):2499-2507.
Stallwood E, Monsour A, Rodrigues C, Monga S, Terwee C, Offringa M, et al. Systematic Review: The Measurement Properties of the Children's Depression Rating Scale-Revised in Adolescents With Major Depressive Disorder. J Am Acad Child Adolesc Psychiatry. 2021;60(1):119-133. doi:10.1016/j.jaac.2020.10.009. PMID: 33130251.
Park K, Jaekal E, Yoon S, Lee SH, Choi KH. Diagnostic Utility and Psychometric Properties of the Beck Depression Inventory-II Among Korean Adults. Front Psychol. 2020 21;10:2934. doi: 10.3389/fpsyg.2019.02934. PMID: 32038360.
Behrens B, Swetlitz C, Pine DS, Pagliaccio D. The Screen for Child Anxiety Related Emotional Disorders (SCARED): Informant Discrepancy, Measurement Invariance, and Test-Retest Reliability. Child Psychiatry Hum Dev. 2019;50(3):473-482. doi: 10.1007/s10578-018-0854-0. PMID: 30460424.
Varni JW, Seid M, Rode CA. The PedsQL: measurement model for the pediatric quality of life inventory. Med Care. 1999;37(2):126-139. doi: 10.1097/00005650-199902000-00003. PMID: 10024117.
Wagner JL, Kellermann T, Mueller M, Smith G, Brooks B, Arnett A, et al. Development and validation of the NDDI-E-Y: a screening tool for depressive symptoms in pediatric epilepsy. Epilepsia. 2016;57(8):1265-1270. doi: 10.1111/epi.13446. Erratum in: Epilepsia. 2018;59(10):2004. doi: 10.1111/epi.14564. PMID: 27354177.
